124.96
+1.80
+(1.46%)
At close: 7:12:20 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 16 | 22 | 20 |
| Avg. Estimate | 1.94B | 2.01B | 8.08B | 8.94B |
| Low Estimate | 1.92B | 1.98B | 7.87B | 8.24B |
| High Estimate | 2.09B | 2.16B | 8.52B | 9.77B |
| Year Ago Sales | 1.82B | 1.88B | 7.43B | 8.08B |
| Sales Growth (year/est) | 6.63% | 6.84% | 8.81% | 10.57% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0TCU.L | -- | -- | -- | -- |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 4/17/2025 |
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 4/15/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/8/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 2/19/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/18/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/18/2025 |